Abstract
Objective: In the present study, the essential oil of Athroisma proteiformis was characterized for the first time.
Method: GC-HRMS (Gas Chromatography-High Resolution Mass Spectrometry) was performed for qualitative and quantitative analysis of the phytochemicals present in the extract. Chemical analyses were conducted to evaluate the total phenols, total flavonoids and antioxidant activity of the extract. Results: Of the 130 peaks detected, 50 were studied and 30 compounds were clearly identified. The main components of the extract were p-cymen-8-ol, the major compound (13.37%), followed by caryophyllene oxide (12.02%), o-cymene (7.79%), humulene epoxide II (7.62%) and limonene (7.35%). The essential oil of Athroisma proteiformis exhibited a good antioxidant activity. The Athroisma extract IC50 values were lower than those of the antioxidant standards used in the FRAP and ABTS tests, ascorbic acid and BHT, and lower than glutathione in the OH radical reducing power test. On the contrary, in the DPPH test, IC50 was higher for A. proteiformis than for ascorbic acid or BHT. Conclusion: It can be concluded that the A. proteiformis plant can be used as a source of natural antioxidants but the consequences on human health should first be carefully studied due to the large number of compounds present in the oil.Keywords: Antioxidant activity, Asteraceae, Athroisma proteiformis, caryophyllene oxide, essential oil, p-Cymen-8-ol.
The Natural Products Journal
Title:Chemical Characterization and Antioxidant Potential of Athroisma proteiformis Essential Oil
Volume: 7 Issue: 3
Author(s): Claudine Aimée Rasolohery, Boniface Erménegilde Ralaibia, Alicia Ayerdi Gotor, Franck Merlier, Rakotonirina Benja, Marcelle Rakotovao and Larbi Rhazi*
Affiliation:
- UniLaSalle BP 30313, Beauvais CEDEX,France
Keywords: Antioxidant activity, Asteraceae, Athroisma proteiformis, caryophyllene oxide, essential oil, p-Cymen-8-ol.
Abstract: Objective: In the present study, the essential oil of Athroisma proteiformis was characterized for the first time.
Method: GC-HRMS (Gas Chromatography-High Resolution Mass Spectrometry) was performed for qualitative and quantitative analysis of the phytochemicals present in the extract. Chemical analyses were conducted to evaluate the total phenols, total flavonoids and antioxidant activity of the extract. Results: Of the 130 peaks detected, 50 were studied and 30 compounds were clearly identified. The main components of the extract were p-cymen-8-ol, the major compound (13.37%), followed by caryophyllene oxide (12.02%), o-cymene (7.79%), humulene epoxide II (7.62%) and limonene (7.35%). The essential oil of Athroisma proteiformis exhibited a good antioxidant activity. The Athroisma extract IC50 values were lower than those of the antioxidant standards used in the FRAP and ABTS tests, ascorbic acid and BHT, and lower than glutathione in the OH radical reducing power test. On the contrary, in the DPPH test, IC50 was higher for A. proteiformis than for ascorbic acid or BHT. Conclusion: It can be concluded that the A. proteiformis plant can be used as a source of natural antioxidants but the consequences on human health should first be carefully studied due to the large number of compounds present in the oil.Export Options
About this article
Cite this article as:
Rasolohery Aimée Claudine, Ralaibia Erménegilde Boniface, Gotor Ayerdi Alicia, Merlier Franck, Benja Rakotonirina, Rakotovao Marcelle and Rhazi Larbi*, Chemical Characterization and Antioxidant Potential of Athroisma proteiformis Essential Oil, The Natural Products Journal 2017; 7 (3) . https://dx.doi.org/10.2174/2210315507666170102154445
DOI https://dx.doi.org/10.2174/2210315507666170102154445 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Reposition of the Fungicide Ciclopirox for Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Pharmacogenetics of Cytochrome P450 (CYP) 1A2 and Variability in Psychotropic Drug Response
Current Psychiatry Reviews Histone Modifier Differentially Regulates Gene Expression and Unravels Survival Role of MicroRNA-494 in Jurkat Leukemia
MicroRNA Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry A Cell Culture Model for the Assessment of the Chemopreventive Potential of Dietary Compounds.
Current Nutrition & Food Science A Connecting Switch Among Aging, Diabetes and Tumor: Avenue Leading to Cancer Therapeutics
Current Cancer Therapy Reviews Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery Molecular Mechanisms of Pancreatic Cancer Dissemination: The Role of the Chemokine System
Current Pharmaceutical Design The Influence of Salinomycin on the Expression Profile of mRNAs Encoding Selected Caspases and MiRNAs Regulating their Expression in Endometrial Cancer Cell Line
Current Pharmaceutical Biotechnology Natural Products as PI3K/ Akt Inhibitors: Implications in Preventing Hepatocellular Carcinoma
Current Molecular Pharmacology Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry MYC-Mediated Synthetic Lethality for Treating Tumors
Current Cancer Drug Targets Q-TOF LC/MS-based Untargeted Metabolomics Approach to Evaluate the Effect of Folate-Conjugated Cyclodextrins on Triple-Negative Breast Cancer Cells
Current Pharmaceutical Analysis Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment
Current Cancer Drug Targets ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development
Current Pharmaceutical Design Evaluation of the in vitro Chemosensitivity and Correlation with Clinical Outcomes in Lung Cancer using the ATP-TCA
Anti-Cancer Agents in Medicinal Chemistry A Discussion of MicroRNAs in Cancers
Current Bioinformatics New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Exploiting APC Function as a Novel Cancer Therapy
Current Drug Targets mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy